Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $2.15 Million - $2.56 Million
-44,297 Reduced 13.69%
279,270 $14.3 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $4.11 Million - $4.59 Million
-70,952 Reduced 17.98%
323,567 $18.8 Million
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $7,963 - $8,842
-125 Reduced 0.03%
394,519 $25.2 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $247,726 - $280,978
-3,770 Reduced 0.95%
394,644 $27.4 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $291,382 - $345,037
-4,255 Reduced 1.06%
398,414 $28.7 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $275 - $162,977
2,121 Added 0.53%
402,669 $28.6 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $308,271 - $339,515
-4,245 Reduced 1.05%
400,548 $30.8 Million
Q1 2022

May 05, 2022

BUY
$61.48 - $73.72 $87,424 - $104,829
1,422 Added 0.35%
404,793 $29.6 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $208,620 - $243,202
3,890 Added 0.97%
403,371 $25.2 Million
Q3 2021

Nov 09, 2021

SELL
$59.17 - $69.31 $803,232 - $940,883
-13,575 Reduced 3.29%
399,481 $23.6 Million
Q2 2021

Jul 14, 2021

SELL
$61.91 - $67.42 $103,575 - $112,793
-1,673 Reduced 0.4%
413,056 $27.6 Million
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $7,120 - $8,008
-120 Reduced 0.03%
414,729 $26.2 Million
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $132,628 - $150,292
-2,297 Reduced 0.55%
414,849 $25.7 Million
Q3 2020

Dec 11, 2020

BUY
$57.43 - $63.64 $349,289 - $387,058
6,082 Added 1.48%
417,146 $25.2 Million
Q2 2020

Dec 16, 2020

BUY
$54.82 - $64.09 $46,597 - $54,476
850 Added 0.21%
411,064 $24.2 Million
Q1 2020

Apr 28, 2020

BUY
$46.4 - $67.43 $236,640 - $343,893
5,100 Added 1.26%
410,214 $22.9 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $361,398 - $471,411
7,344 Added 1.85%
405,114 $26 Million
Q3 2019

Oct 29, 2019

BUY
$42.77 - $50.71 $185,621 - $220,081
4,340 Added 1.1%
397,770 $20.2 Million
Q2 2019

Jul 23, 2019

SELL
$44.62 - $49.34 $332,642 - $367,829
-7,455 Reduced 1.86%
393,430 $17.8 Million
Q1 2019

Apr 24, 2019

BUY
$45.12 - $53.8 $60,054 - $71,607
1,331 Added 0.33%
400,885 $19.1 Million
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $80,697 - $104,645
-1,655 Reduced 0.41%
399,554 $20.8 Million
Q3 2018

Nov 05, 2018

SELL
$55.19 - $62.25 $109,276 - $123,255
-1,980 Reduced 0.49%
401,209 $24.9 Million
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $489,635 - $610,276
9,690 Added 2.46%
403,189 $22.3 Million
Q1 2018

May 02, 2018

BUY
$59.92 - $68.98 $178,981 - $206,043
2,987 Added 0.76%
393,499 $24.9 Million
Q4 2017

Jan 22, 2018

BUY
$59.94 - $65.35 $9,410 - $10,259
157 Added 0.04%
390,512 $23.9 Million
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $21.6 Million - $24.9 Million
390,355
390,355 $24.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track S&Co Inc Portfolio

Follow S&Co Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

News

Stay updated on S&Co Inc with notifications on news.